The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage

Endocrinology

Volumn 138, Issue 9, 1997, Pages 4013-4021

  Weinstein, Robert S ^a,b   Jilka, Robert L ^a   Michael Parfitt, A ^a   Manolagas, Stavros C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; SEX HORMONE;

ANDROGEN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE REMODELING; HORMONE DEFICIENCY; HYPOTHESIS; MOUSE; NONHUMAN; ORCHIECTOMY; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL;

EID: 0030802506     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.9.5359     Document Type: Article

References (11)

1. Manolagas SC, Jilka RL 1995 Bone marrow cytokines and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311
2. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
3. Bellido T, Jilka RJ, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, Manolagas SC 1995 Regulation of interleukin-6, osteoclastogenesis and bone mass by androgens: the role of the androgen receptor. J Clin Invest 95:2886-2895
4. 3. Endocrinology 133:553-562
5. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC 1994 17β-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93:944-950
6. Manolagas SC, Jilka RJ, Bellido T, O'Brien C, Parfitt AM 1996 Interleukin-6-type cytokines and their receptors. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of Bone Biology. Academic Press, San Diego, pp 701-713
7. Passeri G, Girasole G, Jilka RJ, Manolagas SC 1993 Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133:822-828
8. Bismar H, Diel I, Ziegler R, Pfeilschifter J 1995 Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 80:3351-3355
9. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC 199217β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in-vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891
10. Takeda T, Hosokawa M, Higuchi K 1994 Senescence-accelerated mouse (SAM): a novel murine model of aging. In: Takeda T (ed) The SAM Model of Senescence. Excerpta Medica, Elsevier, Amsterdam, pp 15-22
11. Matsushita M, Tsuboyama T, Kasai R, Okumura H, Yamamuro T, Higuchi K, Kohno A, Yonezu T, Utani A 1986 Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am J Pathol 125:276-283